U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Immunity and Disease Prevention Research: Davis, CA
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    Laboratories
                        Stephensen Group
                                    Kable Group
                                    Lemay GroupSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Pacific West Area Davis, California Western Human Nutrition Research Center Immunity and Disease Prevention Research Research Publications at this Location





- ARS National Programs
- Search for a scientific manuscript
- Search for a research project
- ARS Software
- Programs and Projects
- Collaborations
- Subjects of Investigation
- Publications

Title:   Author  item
                                            HARTIALA, JAANA - University Of Southern Californiaitem
                                            LI, DALIN - University Of Southern Californiaitem
                                            CONTI, DAVID - University Of Southern Californiaitem
                                            VIKMAN, SUSANNA - University Of Southern Californiaitem
                                            PATEL, YESHA - University Of Southern Californiaitem
                                            TANG, W. H. WILSON - Cleveland Clinicitem
                                            BRENNAN, MARIE-LOUISE - Cleveland Clinicitem
                                            NEWMAN, JOHN - University Of Southern Californiaitem
                                            Stephensen, Charlesitem
                                            ARMSTRONG, PATRICE - University Of Californiaitem
                                            HAZEN, STANLEY - Cleveland Clinicitem
                                            ALLAYEE, HOOMAN - University Of Southern California
  Submitted to: Human Genetics
                                    Publication Type: Peer Reviewed Journal
                                    Publication Acceptance Date: 1/27/2011
                                    Publication  Date: 6/1/2011
                                    Citation: Hartiala, J., Li, D., Conti, D.V., Vikman, S., Patel, Y., Tang, W., Brennan, M., Newman, J.W., Stephensen, C.B., Armstrong, P., Hazen, S.L., Allayee, H. 2011. Genetic contribution of the leukotriene pathway to coronary artery disease. Human Genetics. 129(6):617-627.Interpretive Summary: Risk of heart disease is influenced by a variety of factors, including both diet and genetics.  This paper shows that normally occurring, common variants in genes of the leukotriene synthesis pathway are associated with risk of heart disease.  This pathway produces mediators of inflammation that influence the formation of arterial plaque, thus modulating the risk of a heart attack.  These mediators are produced from fatty acids found in the diet, thus dietary interventions can reduce the risk of heart disease and this reduced risk is mediated via effects on the same leukotriene synthesis pathway.  The implication of this study is that certain common gene variants increase the risk of heart disease but these findings also suggest that improvements in diet quality may help reduce this risk for subjects with high-risk gene variants.
                                Technical Abstract: We evaluated the genetic contribution of the leukotriene (LT) pathway to risk of coronary artery disease (CAD) in 4,512 Caucasian and African American subjects ascertained through elective cardiac evaluation. Of the three previously associated variants, the shorter "3" and "4" alleles of a promoter repeat polymorphism in ALOX5 increased risk of CAD in African Americans (OR = 1.4, 95% CI 1.0-1.9; p = 0.04), whereas a haplotype of LTA4H (HapK) was associated with CAD in Caucasians (OR = 1.2, 95% CI 1.01-1.4; p = 0.03). In Caucasians, first-stage analysis of 254 haplotype-tagging SNPs in 15 LT pathway genes with follow-up of 19 variants in stage 2 revealed an LTA4H SNP (rs2540477) that increased risk of CAD (OR = 1.2, 95% CI 1.1-1.5; p = 0.003) and a PLA2G4A SNP (rs12746200) that decreased risk of CAD (OR = 0.7, 95% CI 0.6-0.9; p = 0.0007). The PLA2G4A rs12746200 variant also decreased risk of experiencing a major adverse cardiac event (MACE = myocardial infarction, stroke, or death) over 3 years of follow-up (HR = 0.7, 95% CI 0.5-0.9; p = 0.01), consistent with its cardioprotective effect. Functional experiments demonstrated that stimulated monocytes from carriers of LTA4H variants HapK or rs2540477 had 50% (p = 0.002) and 33% (p = 0.03) higher LTB(4) production, respectively, compared to non-carriers. These ex vivo results are consistent with LTB(4) being the direct product of the reaction catalyzed by LTA4H and its role in promoting monocyte chemotaxis to sites of inflammation, including the artery wall of atherosclerotic lesions. Taken together, this study provides additional evidence that functional genetic variation of the LT pathway can mediate atherogenic processes and the risk of CAD in humans.


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov